Cargando…

Current Naturopathy to Combat Alzheimer’s Disease

Neurodegeneration is the progressive loss of structure or function of neurons, which may ultimately involve cell death. The most common neurodegenerative disorder in the brain happens with Alzheimer's disease (AD), the most common cause of dementia. It ultimately leads to neuronal death, thereb...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrovorty, Arnob, Bhattacharjee, Banani, Saxena, Aaruni, Samadder, Asmita, Nandi, Sisir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227918/
https://www.ncbi.nlm.nih.gov/pubmed/36173068
http://dx.doi.org/10.2174/1570159X20666220927121022
_version_ 1785050865401331712
author Chakrovorty, Arnob
Bhattacharjee, Banani
Saxena, Aaruni
Samadder, Asmita
Nandi, Sisir
author_facet Chakrovorty, Arnob
Bhattacharjee, Banani
Saxena, Aaruni
Samadder, Asmita
Nandi, Sisir
author_sort Chakrovorty, Arnob
collection PubMed
description Neurodegeneration is the progressive loss of structure or function of neurons, which may ultimately involve cell death. The most common neurodegenerative disorder in the brain happens with Alzheimer's disease (AD), the most common cause of dementia. It ultimately leads to neuronal death, thereby impairing the normal functionality of the central or peripheral nervous system. The onset and prevalence of AD involve heterogeneous etiology, either in terms of genetic predisposition, neuro-metabolomic malfunctioning, or lifestyle. The worldwide relevancies are estimated to be over 45 million people. The rapid increase in AD has led to a concomitant increase in the research work directed towards discovering a lucrative cure for AD. The neuropathology of AD comprises the deficiency in the availability of neurotransmitters and important neurotrophic factors in the brain, extracellular beta-amyloid plaque depositions, and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Current pharmaceutical interventions utilizing synthetic drugs have manifested resistance and toxicity problems. This has led to the quest for new pharmacotherapeutic candidates naturally prevalent in phytochemicals. This review aims to provide an elaborative description of promising Phyto component entities having activities against various potential AD targets. Therefore, naturopathy may combine with synthetic chemotherapeutics to longer the survival of the patients.
format Online
Article
Text
id pubmed-10227918
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-102279182023-10-11 Current Naturopathy to Combat Alzheimer’s Disease Chakrovorty, Arnob Bhattacharjee, Banani Saxena, Aaruni Samadder, Asmita Nandi, Sisir Curr Neuropharmacol Medicine, Neurology, Pharmacology, Neuroscience Neurodegeneration is the progressive loss of structure or function of neurons, which may ultimately involve cell death. The most common neurodegenerative disorder in the brain happens with Alzheimer's disease (AD), the most common cause of dementia. It ultimately leads to neuronal death, thereby impairing the normal functionality of the central or peripheral nervous system. The onset and prevalence of AD involve heterogeneous etiology, either in terms of genetic predisposition, neuro-metabolomic malfunctioning, or lifestyle. The worldwide relevancies are estimated to be over 45 million people. The rapid increase in AD has led to a concomitant increase in the research work directed towards discovering a lucrative cure for AD. The neuropathology of AD comprises the deficiency in the availability of neurotransmitters and important neurotrophic factors in the brain, extracellular beta-amyloid plaque depositions, and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Current pharmaceutical interventions utilizing synthetic drugs have manifested resistance and toxicity problems. This has led to the quest for new pharmacotherapeutic candidates naturally prevalent in phytochemicals. This review aims to provide an elaborative description of promising Phyto component entities having activities against various potential AD targets. Therefore, naturopathy may combine with synthetic chemotherapeutics to longer the survival of the patients. Bentham Science Publishers 2023-03-30 2023-03-30 /pmc/articles/PMC10227918/ /pubmed/36173068 http://dx.doi.org/10.2174/1570159X20666220927121022 Text en © 2023 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Medicine, Neurology, Pharmacology, Neuroscience
Chakrovorty, Arnob
Bhattacharjee, Banani
Saxena, Aaruni
Samadder, Asmita
Nandi, Sisir
Current Naturopathy to Combat Alzheimer’s Disease
title Current Naturopathy to Combat Alzheimer’s Disease
title_full Current Naturopathy to Combat Alzheimer’s Disease
title_fullStr Current Naturopathy to Combat Alzheimer’s Disease
title_full_unstemmed Current Naturopathy to Combat Alzheimer’s Disease
title_short Current Naturopathy to Combat Alzheimer’s Disease
title_sort current naturopathy to combat alzheimer’s disease
topic Medicine, Neurology, Pharmacology, Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227918/
https://www.ncbi.nlm.nih.gov/pubmed/36173068
http://dx.doi.org/10.2174/1570159X20666220927121022
work_keys_str_mv AT chakrovortyarnob currentnaturopathytocombatalzheimersdisease
AT bhattacharjeebanani currentnaturopathytocombatalzheimersdisease
AT saxenaaaruni currentnaturopathytocombatalzheimersdisease
AT samadderasmita currentnaturopathytocombatalzheimersdisease
AT nandisisir currentnaturopathytocombatalzheimersdisease